United States· US:42385-987_927cba3a-62cf-4e9f-9871-92835927ea46

Oseltamivir

A oseltamivir product containing oseltamivir phosphate, registered in United States by Laurus Labs Limited. The same ATC class is registered in 16 of our 19 countries.

In shortageATC J05AH02Orange BookUS label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedOseltamivirATCJ05AH02REGISTER NO.US:42385-987_927cba3a…PACKS LISTED2CHECKEDSeptember 12, 2026

Where it is registered

Oseltamivir is registered in 16 of 19 countries.

Countries holding a registration under ATC J05AH02 (oseltamivir), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 10 of them publish a price we can compare per daily dose

Oseltamivir · ATC J05AH02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
Oseltamivir phosphate
Manufacturer
Laurus Labs Limited
Country
United States (US)
ATC code
J05AH02
ATC class
Oseltamivir
Defined daily dose
0.15 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 12, 2026

Packs & prices · 2

  • ndc11
    4238598701
    100 CAPSULE in 1 BOTTLE (42385-987-01)
  • ndc11
    4238598711
    1 BLISTER PACK in 1 CARTON (42385-987-11) / 10 CAPSULE in 1 BLISTER PACK (42385-987-10)

Regulatory notes

UNII (FDA substance ID)
4A3O49NGEZ
OSELTAMIVIR PHOSPHATE
RxCUI 259275
Orange Book
A218565
ABABAB
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Oseltamivir Phosphate Capsule

Interactions

93 interactions on record for oseltamivir.

Graded by severity as the source publishes them — 4 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Oseltamivir · interactions on record

93 records

  • 4 moderate
  • 1 minor
  • 88 info

Most severe, free to view

  • MethotrexateL01BA01moderate
  • PemetrexedL01BA04moderate
  • MethotrexateL04AX03moderate
  • MethotrexatM01CX01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Oseltamivir in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All oseltamivir products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Bulgaria · Бетафлу
  • Germany · Oseltamivir Hec Pharm, Oseltamivir Stada
  • Estonia · Segosana
  • Spain · Oseltamivir Accord
  • France · Oseltamivir Zentiva
  • United Kingdom (Northern Ireland) · Oseltamivir, Oseltamivir Accord-Uk
  • Hungary · Segosana
  • Iceland · Ebilfumin, Tamiflu
  • Liechtenstein · Ebilfumin, Tamiflu
  • Lithuania · Segosana
  • Latvia · Segosana
  • Netherlands · Oseltamivir Zentiva, Segosana
  • Norway · Ebilfumin, Tamiflu
  • Poland · Griptavir Med, Oseltamivir Stada
  • Romania · Oseltamivir Accord, Oseltamivir Laropharm

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cde083e4-d7a3-46d5-b655-09a470192eaf
GET /v1/drugs/cde083e4-d7a3-46d5-b655-09a470192eaf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "4A3O49NGEZ",
    "rxcui": "259275",
    "inchikey": "PGZUMBJQJWIWGJ-ONAKXNSWSA-N",
    "display_name": "OSELTAMIVIR PHOSPHATE",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "livertox": {
    "summary": null,
    "livertox_id": null,
    "hepatotoxicity_score": 4
  },
  "spl_meta": {
    "a8a40f98-f6bd-4ef0-af03-93ed0f473c10": {
      "match": "brand_token",
      "title": "OSELTAMIVIR PHOSPHATE CAPSULE [SPORTPHARM LLC]",
      "spl_version": "2",
      "published_date": "2026-04-27"
    }
  },
  "productid": "42385-987_927cba3a-62cf-4e9f-9871-92835927ea46",
  "productndc": "42385-987",
  "dosage_form": "CAPSULE",
  "orange_book": {
    "appl_no": "218565",
    "products": [
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "EQ 30MG BASE",
        "product_no": "001",
        "approval_date": "May 1, 2024"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "EQ 45MG BASE",
        "product_no": "002",
        "approval_date": "May 1, 2024"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "EQ 75MG BASE",
        "product_no": "003",
        "approval_date": "May 1, 2024"
      }
    ],
    "appl_type": "A"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "OSELTAMIVIR PHOSPHATE",
  "shortage_reason": "Oseltamivir Phosphate Capsule",
  "shortage_status": "current",
  "proprietary_name": "Oseltamivir",
  "active_ingred_unit": "mg/1",
  "application_number": "ANDA218565",
  "marketing_category": "ANDA",
  "nonproprietary_name": "Oseltamivir phosphate",
  "start_marketing_date": "20240502",
  "active_numerator_strength": "75"
}

See everything about oseltamivir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.